S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:PMCUF

Pro Medicus (PMCUF) Stock Price, News & Analysis

$67.00
+0.75 (+1.13%)
(As of 03/28/2024 ET)
Today's Range
$67.00
$67.00
50-Day Range
$58.67
$70.75
52-Week Range
$38.19
$70.75
Volume
121 shs
Average Volume
551 shs
Market Capitalization
N/A
P/E Ratio
4,466.67
Dividend Yield
0.03%
Price Target
N/A
PMCUF stock logo

About Pro Medicus Stock (OTCMKTS:PMCUF)

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

PMCUF Stock Price History

PMCUF Stock News Headlines

Pro Medicus Ltd.
Crypto Market Preps For Trillions Worth of Inflows!
Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.
Pro Medicus reports 1H results
Is this as good as it gets for Pro Medicus?
Visage Launches Visage Ease VP™ for Apple Vision Pro
Jefferies Reaffirms Their Hold Rating on Pro Medicus Limited (PMCUF)
Pro Medicus Ltd PMCUF
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
PMCUF Pro Medicus Limited
Pro Medicus Ltd PME
Pro Medicus (ASX:PME) Could Become A Multi-Bagger
Is the stock price surge of Pro Medicus justified
Pro Medicus Limited (PMCUF) Gets a Buy from Wilsons
Pro Medicus Limited (PMCUF) Gets a Hold from Citi
Goldman Sachs Remains a Buy on Pro Medicus Limited (PMCUF)
Moelis Reaffirms Their Hold Rating on Pro Medicus Limited (PMCUF)
Pro Medicus Limited (PMCUF) was upgraded to a Hold Rating at Morgans
Pro Medicus Full Year 2023 Earnings: Beats Expectations
See More Headlines
Receive PMCUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro Medicus and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:PMCUF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Sam Aaron Hupert M.B.B.S.
    M.D., Co-Founder, CEO, MD & Executive Director
  • Mr. Anthony Barry Hall B.Sc.
    B.Sc.(Hons), M.Sc., Co-Founder, Technology Director & Executive Director
  • Mr. Clayton James Hatch B.Comm
    CPA, CPA, Chief Financial Officer
  • Dr. Malte Westerhoff
    GM of Europe & Global CTO
  • Mr. Brad Levin
    GM of North America & Global Head of Marketing
  • Ms. Sharni L. Redenbach
    People & Culture Director
  • Mr. Sean Lambright
    Global Head of Sales - Visage Imaging Inc
  • Ms. Teresa Gschwind
    Global Head of Customer Service of Visage Imaging Inc.
  • Ms. Danny English C.A.
    Financial Controller & Company Secretary

PMCUF Stock Analysis - Frequently Asked Questions

Should I buy or sell Pro Medicus stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Pro Medicus in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PMCUF shares.
View PMCUF analyst ratings
or view top-rated stocks.

How have PMCUF shares performed in 2024?

Pro Medicus' stock was trading at $64.75 at the beginning of 2024. Since then, PMCUF shares have increased by 3.5% and is now trading at $67.00.
View the best growth stocks for 2024 here
.

Are investors shorting Pro Medicus?

Pro Medicus saw a decrease in short interest in February. As of February 29th, there was short interest totaling 301,000 shares, a decrease of 17.6% from the February 14th total of 365,400 shares. Based on an average daily volume of 700 shares, the days-to-cover ratio is currently 430.0 days.
View Pro Medicus' Short Interest
.

Is Pro Medicus a good dividend stock?

Pro Medicus (OTCMKTS:PMCUF) pays an annual dividend of $0.02 per share and currently has a dividend yield of 1.63%. The dividend payout ratio is 133.33%. Payout ratios above 75% are not desirable because they may not be sustainable.

How do I buy shares of Pro Medicus?

Shares of PMCUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PMCUF) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners